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With very few exceptions, topical 
administration of contact allergens—at 
concentrations sufficient for the acqui-
sition of skin sensitization—is associ-
ated with the rapid mobilization of a 
fraction of epidermal Langerhans cells 
(LCs) at the site of exposure, as well as 
their migration away from the skin. This 
is true for humans and mice, and with 
respect to LC function, these species 
display striking commonality regarding 
cell frequency within the epidermis, the 
cytokine signals required for mobiliza-
tion, and the tempo of migration (Kimber 
et al., 2000; Griffiths et al., 2005).
The classic paradigm has been that 
LCs form an epidermal net to trap anti-
gens—including chemical allergens—
encountered at skin surfaces, and that 
these cells are responsible for the pro-
cessing, transport, and presentation of 
allergens—or allergen-modified pep-
tides—to responsive T lymphocytes. 
The legitimacy of this interpretation 
has been challenged recently by the 
availability of mice lacking LCs and 
by the use of complementary experi-
mental strategies. The picture is com-
plicated, but a case can be made that 
there are circumstances in which the 
presentation of topically applied chem-
ical allergens—and the development 
of skin sensitization—can proceed 
without LCs (Kaplan et al., 2005; 
Romani et al., 2006; Kissenpfennig 
and Malissen, 2006; Bennett et al., 
2007; Wang et al., 2008; Fukunaga et 
al., 2008).
One interpretation—the one we 
currently favor—is that in intact skin 
containing the normal complement 
of LC and dermal dendritic cell (DC) 
populations, LCs, possibly in tandem 
with other DCs, play pivotal roles in 
antigen delivery, processing, and pre-
sentation, and the effective translation 
of antigen encounters into an adaptive 
immune response. If, however, LCs are 
absent or functionally incapacitated, 
then dermal DCs can and will act in 
their place. This is not a novel inter-
pretation. Two decades ago, using a 
palette of experimental approaches, 
the late and greatly lamented Wayne 
Streilein came to exactly the same 
conclusion (Streilein, 1989). To para-
phrase the title of his elegant paper, 
Streilein concluded that “Langerhans 
cells are sufficient, but not required,” 
for the induction of skin sensitization 
in mice. What is new, however, is that 
more recent investigations inform us 
that, in addition to antigen delivery 
and presentation, epidermal LCs may 
have immunoregulatory properties that 
serve to contain and constrain adap-
tive immune responses in the skin.
Of course, a more complex function-
al profile, if anything, makes LCs and 
their roles in skin sensitization even 
more interesting subjects for investiga-
tion. Reines and colleagues (2009, this 
issue) report on the relationship among 
LC mobilization, the activation of drain-
ing lymph nodes, and the acquisition of 
skin sensitization. For this purpose, the 
authors have made use of sphingosine-
1-phosphate (S1P) and a novel immu-
nomodulator, Fingolimod (FTY720), to 
dissect the induction phase of skin sen-
sitization in mice. When administered 
orally to mice, S1P and FTY720 were 
previously shown to cause altered lym-
phocyte trafficking and marked lym-
phopenia, effects secondary to agonism 
of a family of S1P receptors (S1PRs; 
Mandala et al., 2002).
The approach taken by Reines et al. 
has been to explore the impact of topi-
cal administration of S1P and FTY720 
on the induction and elicitation in mice 
of contact hypersensitivity to toluene 
diisocyanate (TDI), a known chemi-
cal allergen. Topical treatment with the 
S1PR agonists resulted in significant 
reductions in the weight and cellular-
ity of regional lymph nodes draining 
the site of exposure to TDI, and a case 
is made that this is caused by an asso-
ciated reduction in the ability of local 
LCs to become mobilized in response 
to TDI in mice treated with the agonists. 
Whether such a case is sustainable is 
uncertain, mainly because even local 
treatment with S1PR agonists caused 
systemic leukopenia and lymphopenia. 
It is therefore difficult to prove conclu-
sively that the compromised immune 
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activation of draining lymph nodes 
was attributable exclusively to induced 
inhibition of LC mobilization, rather 
than a consequence (at least in part) of 
systemic effects on lymphocyte traffick-
ing and homing. Nevertheless, even if 
some uncertainty exists about a direct 
causal relationship among S1PR ago-
nists, impaired LC mobilization, and 
the acquisition of skin sensitization, 
these investigations draw attention to 
an association between LC migration 
and contact allergen–induced changes 
in regional lymph nodes that signal the 
early stages of sensitization.
The coming months and years will 
undoubtedly witness a much clearer 
definition of the cellular and molecular 
mechanisms required for the effective 
induction of skin sensitization, in par-
ticular the roles that LCs play in orches-
trating the process.
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Protein Kinase Cε Reveals Importance 
of extrinsic Apoptosis in Preventing 
UV Carcinogenesis
Frank de Gruijl1
UV-induced apoptosis, giving rise to “sunburn cells,” has been thought to be 
primarily cell autonomous (or intrinsic) in nature, triggered by DNA damage 
and mediated through p53. However, in vivo the microenvironment appears to 
contribute to UV-induced apoptosis by activating the extrinsic route through 
death receptors. Protein kinase Cε lowers UV-induced expression of fas and 
its downstream proteins in this extrinsic route, suppressing apoptosis and 
enhancing UV carcinogenesis.
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Protein kinase c and cell fate
Protein kinase C (PKC) is the tar-
get of the skin tumor promoter 
12-O-tetradecanoylphorbol 13-acetate 
(TPA), and it can be activated through 
growth factor receptors such as EGFR. 
PKC occurs as a family of 10 isotypes: 4 
classical isotypes (α, βI, βII, and γ) that 
depend on phospholipids and calcium 
for their activation; 4 novel isotypes 
(δ, ε, η, and θ) that are not dependent 
on calcium; and 2 atypical isotypes 
(ζ and ι/λ) that are not dependent on 
either phospholipids or calcium. The 
PKCs play roles in many cellular pro-
cesses, including proliferation, motil-
ity, differentiation, and apoptosis—all 
of which are of direct importance to 
carcinogenesis, including skin carcino-
genesis (Breitkreutz et al., 2007). As 
determined by the expression of adhe-
sion molecules, cPKCβ and nPKCε 
induce the phenotype of basal cells 
in keratinocytes, whereas cPKCα and 
nPKCδ induce molecules that typify 
differentiated cells (Szegedi et al., 2009). 
PKC isotypes are differentially expressed 
in the basal proliferative and overlying 
differentiated layers (Verma et al., 2006). 
Although they are archetypal tumor pro-
moters, phorbol esters, like TPA, can 
have different effects, depending on the 
cell type; e.g., instead of growth, andro-
gen-dependent prostate cancer cells 
undergo apoptosis through excretion 
of death factors, whereas lung cancer 
cells undergo senescence (Xiao et al., 
2008). The outcome may depend on the 
balance of effects among PKC isotypes. 
PKCδ has been reported to promote 
apoptosis, whereas most of the others 
appear to exert the opposite effect, pro-
moting survival and proliferation. PKCε, 
in particular, qualifies as a genuine 
oncogene—it activates RhoA/C, Stat3, 
and Akt, and it increases cell survival, 
proliferation, motility, and invasion. It 
is overexpressed in tumors from various 
organs, and it may serve as a tumor bio-
marker (Gorin and Pan, 2009).
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